Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Olumiant 4 mg Film-Coated Tablets

Discontinued
Active Ingredient:
baricitinib
Company:  
Eli Lilly and Company Limited See contact details
ATC code: 
L04AA37
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials Product Information Live Chat HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Olumiant 2 mg and 4 mg Film-Coated Tablets guidance for Healthcare Professionals for Atopic Dermatitis and Alopecia Areata

{healthcare_pro_orange} For Healthcare Professionals
Important Risk Minimization information for healthcare professionals prescribing Olumiant for the treatment of Atopic Dermatitis and Alopecia Areata.
{pdf_link}

Olumiant 2 mg and 4 mg Film-Coated Tablets guidance for Healthcare Professionals for Rheumatoid Arthritis

{healthcare_pro_orange} For Healthcare Professionals
Important Risk Minimization information for healthcare professionals prescribing Olumiant for the treatment of Rheumatoid Arthritis.
{pdf_link}

Olumiant 2 mg and 4 mg Film-Coated Tablets Patient Alert Card

Olumiant 2 mg and 4 mg Film-Coated Tablets Patient Alert Card containing important safety information for patients.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Eli Lilly and Company Limited
Company image
Address
Lilly House, Basing View, Basingstoke, Hampshire, RG21 4FA
WWW
https://www.lilly.com/uk/
Telephone
+44 (0)1256 315 000
Medical Information Website
https://www.lillymedical.co.uk/en-gb
Medical Information e-mail
[email protected]